Regulatory Watch
June 2025: FDA raids Amino Asylum warehouse; website goes offline, operations cease Feb 2025: FDA declares semaglutide shortage resolved — compounding exception ends Sept 2025: FDA issues 50+ warning letters to GLP-1 compounders; DOJ involvement confirmed Nov 2025: Alabama obtains TRO against GLP-1 distributors — first state-level injunctive relief Sept 2023: FDA moves BPC-157, TB-500, and 15 other peptides to Category 2 — compounding prohibited Dec 2024: PCAC votes against allowing compounding of ipamorelin, MK-677, CJC-1295, AOD-9604 Jan 2025: FDA eliminates Category 2/3 system; prohibited substances remain prohibited Feb 2026: STAT News: 35 of 36 BPC-157 studies are animal-only from single lab with undisclosed conflicts 2025: Chinese peptide imports to US double to $328M; online peptide advertising up 678% since 2022 June 2025: FDA raids Amino Asylum warehouse; website goes offline, operations cease Feb 2025: FDA declares semaglutide shortage resolved — compounding exception ends Sept 2025: FDA issues 50+ warning letters to GLP-1 compounders; DOJ involvement confirmed Nov 2025: Alabama obtains TRO against GLP-1 distributors — first state-level injunctive relief Sept 2023: FDA moves BPC-157, TB-500, and 15 other peptides to Category 2 — compounding prohibited Dec 2024: PCAC votes against allowing compounding of ipamorelin, MK-677, CJC-1295, AOD-9604 Jan 2025: FDA eliminates Category 2/3 system; prohibited substances remain prohibited Feb 2026: STAT News: 35 of 36 BPC-157 studies are animal-only from single lab with undisclosed conflicts 2025: Chinese peptide imports to US double to $328M; online peptide advertising up 678% since 2022

Verified Peptides

verifiedpeptides.com ↗
Founded: 2020 HQ: USA Last reviewed: February 20, 2026
B
Overall Grade
Transparency 75/100
Testing 75/100
Pricing 55/100
Reputation 65/100
Compliance 60/100
Publishes COA Yes
Third-Party Testing Yes
FDA Warning Letters 0
Product Types injectable, lyophilized-powder, research-chemical

Verified Peptides

Overview

Verified Peptides was founded in 2020 as one of the first vendors to make third-party lab testing a core brand identity. With over 300 published lab reports, 34 Finnrick-tested samples across 8 products, GMP-certified US manufacturing, and credit card acceptance (rare in this market), the company has built a testing-forward reputation. The name itself is a positioning statement — and the data largely backs it up.

What We Found

Testing & Quality (Score: 70/100)

Finnrick Analytics tested 34 samples across 8 products, with ratings ranging from A to C:

  • A ratings on top products indicate excellent purity and quantity accuracy
  • C ratings on some products indicate acceptable but not exceptional performance
  • The range (A to C) suggests product-by-product variability rather than uniform excellence

Beyond Finnrick, the company claims:

  • 300+ published lab reports since 2019 (pre-founding claim suggests continuity from prior operations)
  • Every batch sent to third-party analytical testing labs recognized by the research community
  • Testing for purity, net peptide content, endotoxins (lipopolysaccharides), and sterile analysis of bacterial/yeast
  • Public lab test archive on their website

The endotoxin and sterility testing claims are significant — these are tests most grey-market vendors skip entirely, and they’re the tests most relevant to injection safety. If consistently performed, this places Verified Peptides’ testing program among the most comprehensive available.

Transparency (Score: 70/100)

Strong transparency indicators:

  • Public lab test page with extensive archive
  • Batch-specific COAs with verification capability
  • GMP facility claims for US manufacturing
  • 30-day money-back guarantee (extremely rare in this market)
  • Credit card acceptance — payment processors vet vendors, adding an accountability layer

The money-back guarantee is a meaningful trust signal: it’s nearly unheard of among grey-market peptide vendors and suggests confidence in product quality.

Pricing (Score: 60/100)

Mid-range pricing. The “buy more, save more” program offers up to 15% off bulk orders. Free shipping thresholds apply. Pricing is competitive given the testing investment, though not the cheapest option available.

Reputation (Score: 65/100)

Claimed 270+ 5-star Trustpilot reviews. Founded in 2020 with claimed biochemistry expertise since 2012. The “Join over 5,000 active members” community claim suggests meaningful customer base. Credit card acceptance is repeatedly cited as a trust differentiator — payment processors perform their own vendor vetting.

Compliance (Score: 60/100)

Standard research-use disclaimers. GMP-certified US manufacturing claim, if accurate, represents a higher operational standard than most grey-market operations. Credit card acceptance means the company passes financial compliance checks that many competitors fail. No known FDA enforcement actions.

The PeptideExaminer Verdict

Verified Peptides lives up to its name more than most: 300+ published lab reports, Finnrick testing across 8 products, endotoxin/sterility testing, GMP claims, credit card acceptance, and a money-back guarantee create a layer cake of accountability that’s unusual in this market. The A-to-C Finnrick range suggests some products are better than others, which is honest reporting rather than suspicious uniformity. The money-back guarantee and credit card acceptance are particularly meaningful trust signals — vendors confident enough to accept chargebacks and returns are signaling real quality commitment.

Grade: B

CategoryScoreWeightWeighted
Transparency7020%14.0
Testing7025%17.5
Pricing6015%9.0
Reputation6520%13.0
Compliance6020%12.0
Total65.5 → B

Sources: Finnrick Analytics (finnrick.com, 34 samples), verifiedpeptides.com, Trustpilot